Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative autoimmune disorder of the central nervous system characterized by demyelination and neurodegeneration. Traditionally considered a T-cell-mediated disease, the crucial role of B lymphocytes in its pathogenesis, through different...
Saved in:
| Main Authors: | Federica Galota, Simone Marcheselli, Sara De Biasi, Lara Gibellini, Francesca Vitetta, Alessia Fiore, Krzysztof Smolik, Giulia De Napoli, Martina Cardi, Andrea Cossarizza, Diana Ferraro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/8/606 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The immunological bases of alemtuzumab as induction-therapy in pediatric-onset multiple sclerosis
by: Marco Puthenparampil, et al.
Published: (2025-01-01) -
Assessment of the impact of reconstitution therapies—cladribine tablets and alemtuzumab—on the atrophy progression among patients with relapse-remitting multiple sclerosis
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-02-01) -
The role of alemtuzumab in the development of secondary autoimmunity in multiple sclerosis: a systematic review
by: Sofia Jimenez-Sanchez, et al.
Published: (2024-11-01) -
Retrospective, multi-centre, open-label study on the use of alemtuzumab for relapsing–remitting multiple sclerosis in clinical practice: A 4-year follow-up
by: A. Pato-Pato, et al.
Published: (2025-07-01) -
New autoimmune disorder development after immune reconstitution therapy for multiple sclerosis
by: Nataša Giedraitienė, et al.
Published: (2024-12-01)